Monitor drug safety and pedigree legislation. Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus.  Issues relating to comparative effectiveness and CMS converage of FDA approved therapies.  Issues related to the PPS rule involving stroke guidelines. Implementation of the follow-on biolotics provisions in P.L. 111-148- "Patient Protection and Affordable Care Act". Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus.  Issues relating to comparative effectiveness and CMS converage of FDA approved therapies.  Issues related to the PPS rule involving stroke guidelines.
PHA - Pharmacy HCR - Health Issues MMM - Medicare/Medicaid
11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RYAN MACKINNON VASAPOLI AND BERZOK, LLP
1634 I Street, NW Suite 1200, Washington, DC, 20006, US
THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS